News

LIVER cells have been found to have their own ability to burn accumulated fat, according to Swedish researchers. A new clinical trial has been planned…

PEMBROLIZUMAB, a highly selective, humanised monoclonal antibody targeting programmed cell death 1 (PD-1), has a superior safety profile and improved…

RESULTS published from a Phase II clinical trial have shown the potential of the investigational drug savolitinib in the treatment of c-MET-driven…

Tel-Aviv, Israel, March 21, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty…

One of the most exciting events for medical innovation in the UK, WIRED Health took place this year on 9th March with a packed agenda bursting with…

A REVOLUTIONARY treatment has been developed for the surgical dispersal of retinal vein occlusion clots. The procedure would not have been possible…

HUMAN skin has been successfully synthesised using a three-dimensional (3D) bioprinter. Researchers at the Universidad Carlos III de Madrid, Madrid…

Kraków, Poland, March 17, 2017 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for patients…